Vimta Labs Limited (VIMTALABS) — Announcement(2 announcements)

· NSE 🔴 High Importance Neutral
1 Announcement 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Company confirms no share encumbrances under SEBI takeover norms
💡 Investor Takeaway
This confirms promoter shareholding remains unencumbered, supporting stability in control.

Vimta Labs Limited disclosed under SEBI Takeover Regulations that, as of March 31, 2026, it and related parties had not encumbered any shares held by promoters or those acting in concert during the financial year, confirming compliance with Regulation 31(4) of the Substantial Acquisition of Shares and Takeovers Regulations, 2011.

2 Announcement Neutral 📄 PDF
📢 Key Event
Vimta Labs schedules analyst meeting with Goldman Sachs
💡 Investor Takeaway
Investors can engage directly with management to gain insights into the company's strategy and performance.

Vimta Labs Limited announced a scheduled in-person investor meeting with Goldman Sachs on June 11, 2026, from 2:00 PM to 3:30 PM at its Hyderabad office, providing analysts and institutional investors a platform to discuss the company's performance and strategy without disclosing price-sensitive information.

About Vimta Labs Limited (VIMTALABS)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹2,012.35 Cr P/E: 32.8

View full VIMTALABS stock details →

📡 Get AI alerts when VIMTALABS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIMTALABS — Free

📊 More VIMTALABS filings

See all VIMTALABS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when VIMTALABS files new disclosures

Track VIMTALABS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIMTALABS — Free

Free account · 2 AI queries/day